Icon reports more expectation-beating results

This article was originally published here
Share

Medtech, pharma and biotech development outsourcer Icon continues to beat the Street when it comes to its results.

Dublin, Ireland–based Icon (Nasdaq:ICLR) said today that it earned $78.5 million, or $1.43 per share, off $455.1 million in sales for the fourth quarter ended Dec. 31, 2017 – up from $74.3 million, or $1.33 per share, in profits off $435.1 million in revenue for the same quarter a year before.

Analysts on average had expected fourth-quarter profits of $1.42 per share off $454.6 million in revenue, according to Yahoo Finance.

Get the full story on our sister site Medical Design & Outsourcing.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply